

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of protein oligomerization (GO:0032460) | 8.59500575 |
| 2 | sterol catabolic process (GO:0016127) | 6.28807981 |
| 3 | cholesterol catabolic process (GO:0006707) | 6.28807981 |
| 4 | positive regulation of protein sumoylation (GO:0033235) | 6.17201146 |
| 5 | neuron remodeling (GO:0016322) | 5.87682233 |
| 6 | regulation of protein homooligomerization (GO:0032462) | 5.80962098 |
| 7 | regulation of axon regeneration (GO:0048679) | 5.51795518 |
| 8 | regulation of neuron projection regeneration (GO:0070570) | 5.51795518 |
| 9 | snRNA processing (GO:0016180) | 5.49595956 |
| 10 | negative regulation of dendrite development (GO:2000171) | 5.38702916 |
| 11 | positive regulation of T cell chemotaxis (GO:0010820) | 5.37937316 |
| 12 | regulation of T cell chemotaxis (GO:0010819) | 5.37937316 |
| 13 | snRNA metabolic process (GO:0016073) | 5.14032963 |
| 14 | positive regulation of protein deacetylation (GO:0090312) | 4.47879753 |
| 15 | striatum development (GO:0021756) | 4.33858475 |
| 16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.32547071 |
| 17 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.25623579 |
| 18 | regulation of collateral sprouting (GO:0048670) | 4.25432550 |
| 19 | macroautophagy (GO:0016236) | 4.11090822 |
| 20 | regulation of protein sumoylation (GO:0033233) | 4.01300817 |
| 21 | positive regulation of B cell differentiation (GO:0045579) | 3.97837216 |
| 22 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.90936765 |
| 23 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.88104747 |
| 24 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.81505424 |
| 25 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.81505424 |
| 26 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.70408053 |
| 27 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.68651149 |
| 28 | glandular epithelial cell development (GO:0002068) | 3.64189142 |
| 29 | regulation of protein oligomerization (GO:0032459) | 3.61198993 |
| 30 | barbed-end actin filament capping (GO:0051016) | 3.54412654 |
| 31 | regulation of regulatory T cell differentiation (GO:0045589) | 3.48597766 |
| 32 | steroid catabolic process (GO:0006706) | 3.47652899 |
| 33 | phagocytosis, engulfment (GO:0006911) | 3.43556041 |
| 34 | regulation of gamma-delta T cell activation (GO:0046643) | 3.39182892 |
| 35 | response to interleukin-15 (GO:0070672) | 3.38138640 |
| 36 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.36967948 |
| 37 | response to oxygen radical (GO:0000305) | 3.36867594 |
| 38 | alpha-linolenic acid metabolic process (GO:0036109) | 3.36190803 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.35606675 |
| 40 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 3.34307444 |
| 41 | erythrocyte maturation (GO:0043249) | 3.29178368 |
| 42 | retinoic acid receptor signaling pathway (GO:0048384) | 3.24074906 |
| 43 | interferon-gamma production (GO:0032609) | 3.23059440 |
| 44 | nerve growth factor signaling pathway (GO:0038180) | 3.22622094 |
| 45 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.22066542 |
| 46 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 3.17797475 |
| 47 | UMP metabolic process (GO:0046049) | 3.17797475 |
| 48 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 3.17797475 |
| 49 | UMP biosynthetic process (GO:0006222) | 3.17797475 |
| 50 | keratan sulfate catabolic process (GO:0042340) | 3.13506714 |
| 51 | regulation of timing of cell differentiation (GO:0048505) | 3.13102761 |
| 52 | T cell homeostasis (GO:0043029) | 3.12959758 |
| 53 | hematopoietic stem cell differentiation (GO:0060218) | 3.11780149 |
| 54 | regulation of mitochondrial fission (GO:0090140) | 3.07549138 |
| 55 | positive regulation of histone deacetylation (GO:0031065) | 3.05323546 |
| 56 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.04591368 |
| 57 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.02699780 |
| 58 | cellular response to interleukin-15 (GO:0071350) | 3.02028227 |
| 59 | B cell receptor signaling pathway (GO:0050853) | 3.01984091 |
| 60 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.97546387 |
| 61 | regulation of B cell differentiation (GO:0045577) | 2.93637396 |
| 62 | negative regulation of interleukin-17 production (GO:0032700) | 2.93328467 |
| 63 | quinone biosynthetic process (GO:1901663) | 2.93320641 |
| 64 | ubiquinone biosynthetic process (GO:0006744) | 2.93320641 |
| 65 | negative regulation of protein autophosphorylation (GO:0031953) | 2.92351062 |
| 66 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.91014022 |
| 67 | negative regulation of axon extension (GO:0030517) | 2.84864878 |
| 68 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.82217925 |
| 69 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.82217925 |
| 70 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.82217925 |
| 71 | megakaryocyte development (GO:0035855) | 2.81791747 |
| 72 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.78217752 |
| 73 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.76218933 |
| 74 | low-density lipoprotein particle clearance (GO:0034383) | 2.74487018 |
| 75 | gene silencing by RNA (GO:0031047) | 2.72958091 |
| 76 | regulation of erythrocyte differentiation (GO:0045646) | 2.72509800 |
| 77 | cellular response to ethanol (GO:0071361) | 2.71398878 |
| 78 | detection of other organism (GO:0098543) | 2.70139052 |
| 79 | rRNA methylation (GO:0031167) | 2.64824713 |
| 80 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.64149875 |
| 81 | negative regulation of cell killing (GO:0031342) | 2.64149875 |
| 82 | purine nucleotide salvage (GO:0032261) | 2.64147948 |
| 83 | definitive hemopoiesis (GO:0060216) | 2.63400488 |
| 84 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.63034543 |
| 85 | endosome to melanosome transport (GO:0035646) | 2.62430304 |
| 86 | endosome to pigment granule transport (GO:0043485) | 2.62430304 |
| 87 | oxaloacetate metabolic process (GO:0006107) | 2.62031886 |
| 88 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.61532295 |
| 89 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.61045654 |
| 90 | phosphatidylinositol dephosphorylation (GO:0046856) | 2.58334955 |
| 91 | lymphocyte homeostasis (GO:0002260) | 2.57703600 |
| 92 | regulation of development, heterochronic (GO:0040034) | 2.57037734 |
| 93 | membrane invagination (GO:0010324) | 2.56991998 |
| 94 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.56377432 |
| 95 | phospholipid dephosphorylation (GO:0046839) | 2.55304603 |
| 96 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 2.54162091 |
| 97 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.53981977 |
| 98 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.52552462 |
| 99 | regulation of extracellular matrix disassembly (GO:0010715) | 2.52514863 |
| 100 | complement activation, alternative pathway (GO:0006957) | 2.52375256 |
| 101 | negative regulation of complement activation (GO:0045916) | 2.51122504 |
| 102 | detection of molecule of bacterial origin (GO:0032490) | 2.50569701 |
| 103 | ubiquinone metabolic process (GO:0006743) | 2.50322252 |
| 104 | valine metabolic process (GO:0006573) | 2.48563757 |
| 105 | fibril organization (GO:0097435) | 2.48262874 |
| 106 | cellular response to epinephrine stimulus (GO:0071872) | 2.48118361 |
| 107 | response to caffeine (GO:0031000) | 2.46860364 |
| 108 | positive regulation of protein homodimerization activity (GO:0090073) | 2.45929312 |
| 109 | mitochondrial genome maintenance (GO:0000002) | 2.44536081 |
| 110 | germinal center formation (GO:0002467) | 2.42332271 |
| 111 | extracellular fibril organization (GO:0043206) | 2.41254801 |
| 112 | chondroitin sulfate catabolic process (GO:0030207) | 2.41138855 |
| 113 | apoptotic cell clearance (GO:0043277) | 2.38919409 |
| 114 | negative regulation of protein activation cascade (GO:2000258) | 2.38818500 |
| 115 | positive regulation of macrophage cytokine production (GO:0060907) | 2.33392540 |
| 116 | regulation of macrophage cytokine production (GO:0010935) | 2.29230103 |
| 117 | lipid storage (GO:0019915) | 2.28450883 |
| 118 | triglyceride catabolic process (GO:0019433) | 2.27945955 |
| 119 | positive regulation of cholesterol transport (GO:0032376) | 2.24453134 |
| 120 | positive regulation of sterol transport (GO:0032373) | 2.24453134 |
| 121 | import into cell (GO:0098657) | 2.23101439 |
| 122 | positive regulation of cholesterol efflux (GO:0010875) | 2.20512259 |
| 123 | negative regulation of humoral immune response (GO:0002921) | 2.18573304 |
| 124 | iron ion import (GO:0097286) | 2.17631897 |
| 125 | positive regulation of receptor recycling (GO:0001921) | 2.17539730 |
| 126 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.16734304 |
| 127 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.15158800 |
| 128 | neutral lipid catabolic process (GO:0046461) | 2.11504912 |
| 129 | acylglycerol catabolic process (GO:0046464) | 2.11504912 |
| 130 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.09810881 |
| 131 | regulation of cholesterol storage (GO:0010885) | 2.09416960 |
| 132 | detection of external biotic stimulus (GO:0098581) | 2.08864184 |
| 133 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.06623074 |
| 134 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.05797396 |
| 135 | regulation of sequestering of triglyceride (GO:0010889) | 2.05694268 |
| 136 | regulation of beta-amyloid formation (GO:1902003) | 2.05471216 |
| 137 | macrophage activation involved in immune response (GO:0002281) | 2.04721383 |
| 138 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.04396508 |
| 139 | positive regulation of glycolytic process (GO:0045821) | 2.03033795 |
| 140 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.02803148 |
| 141 | induction of positive chemotaxis (GO:0050930) | 2.01492617 |
| 142 | type B pancreatic cell proliferation (GO:0044342) | 2.01053798 |
| 143 | response to dietary excess (GO:0002021) | 2.00368759 |
| 144 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.00286995 |
| 145 | response to epinephrine (GO:0071871) | 1.98368979 |
| 146 | regulation of complement activation (GO:0030449) | 1.98228660 |
| 147 | negative regulation of smooth muscle cell migration (GO:0014912) | 1.98003222 |
| 148 | ethanol oxidation (GO:0006069) | 1.97054316 |
| 149 | negative regulation of type 2 immune response (GO:0002829) | 1.96130245 |
| 150 | hypotonic response (GO:0006971) | 1.96099934 |
| 151 | regulation of platelet aggregation (GO:0090330) | 1.95338586 |
| 152 | positive regulation of triglyceride lipase activity (GO:0061365) | 1.94575371 |
| 153 | positive regulation of lipoprotein lipase activity (GO:0051006) | 1.94575371 |
| 154 | cortical actin cytoskeleton organization (GO:0030866) | 1.93232933 |
| 155 | stress fiber assembly (GO:0043149) | 1.92762776 |
| 156 | regulation of protein activation cascade (GO:2000257) | 1.92557830 |
| 157 | amino sugar catabolic process (GO:0046348) | 1.92233099 |
| 158 | regulation of cholesterol esterification (GO:0010872) | 1.91895430 |
| 159 | adhesion of symbiont to host cell (GO:0044650) | 1.90243970 |
| 160 | virion attachment to host cell (GO:0019062) | 1.90243970 |
| 161 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 1.88911323 |
| 162 | toxin transport (GO:1901998) | 1.87658842 |
| 163 | neutrophil activation involved in immune response (GO:0002283) | 1.87351848 |
| 164 | positive regulation of fibroblast migration (GO:0010763) | 1.86644488 |
| 165 | cellular response to vitamin (GO:0071295) | 1.86416647 |
| 166 | protein localization to endosome (GO:0036010) | 1.86184368 |
| 167 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 1.85890164 |
| 168 | transcytosis (GO:0045056) | 1.85684643 |
| 169 | positive regulation of extracellular matrix organization (GO:1903055) | 1.85172361 |
| 170 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 1.84480290 |
| 171 | regulation of phospholipase A2 activity (GO:0032429) | 1.83237523 |
| 172 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 1.82916372 |
| 173 | cellular extravasation (GO:0045123) | 1.81398743 |
| 174 | cellular response to zinc ion (GO:0071294) | 1.81361536 |
| 175 | cortical cytoskeleton organization (GO:0030865) | 1.80648713 |
| 176 | plasma lipoprotein particle clearance (GO:0034381) | 1.80308136 |
| 177 | regulation of ARF protein signal transduction (GO:0032012) | 1.79979517 |
| 178 | regulation of T-helper 2 cell differentiation (GO:0045628) | 1.79237666 |
| 179 | regulation of plasminogen activation (GO:0010755) | 1.79234542 |
| 180 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 1.79156284 |
| 181 | cellular response to cadmium ion (GO:0071276) | 1.78973152 |
| 182 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 1.78633131 |
| 183 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 1.78588616 |
| 184 | positive regulation of phagocytosis (GO:0050766) | 1.78579581 |
| 185 | macrophage activation (GO:0042116) | 1.78504673 |
| 186 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 1.78419205 |
| 187 | fatty acid homeostasis (GO:0055089) | 1.78246892 |
| 188 | xenobiotic catabolic process (GO:0042178) | 1.78144296 |
| 189 | protein carboxylation (GO:0018214) | 1.77897188 |
| 190 | peptidyl-glutamic acid carboxylation (GO:0017187) | 1.77897188 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.72668010 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 4.08793736 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.03953512 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.54287163 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.46643098 |
| 6 | GATA1_22025678_ChIP-Seq_K562_Human | 3.34184060 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.24892232 |
| 8 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.93341524 |
| 9 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.78496024 |
| 10 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.70767343 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.64942361 |
| 12 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.47477955 |
| 13 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.40645766 |
| 14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.33060692 |
| 15 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28485463 |
| 16 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.22414340 |
| 17 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.21962591 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.21139849 |
| 19 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.18954036 |
| 20 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.15928429 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.14995191 |
| 22 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.11863573 |
| 23 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.10404059 |
| 24 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.07655991 |
| 25 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.04841607 |
| 26 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.00326116 |
| 27 | MAF_26560356_Chip-Seq_TH1_Human | 1.99654161 |
| 28 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.92632729 |
| 29 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.92072798 |
| 30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.91934870 |
| 31 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.90052505 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.89905166 |
| 33 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.88839493 |
| 34 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.87804827 |
| 35 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.87046799 |
| 36 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.85504648 |
| 37 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.83445780 |
| 38 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.83207357 |
| 39 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.82971679 |
| 40 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.81047606 |
| 41 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.78195104 |
| 42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.77595492 |
| 43 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.73311980 |
| 44 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.73140104 |
| 45 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.73064352 |
| 46 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.70675068 |
| 47 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.68307989 |
| 48 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.67092557 |
| 49 | SPI1_23127762_ChIP-Seq_K562_Human | 1.65726224 |
| 50 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.65024895 |
| 51 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.63944876 |
| 52 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.63511239 |
| 53 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63292571 |
| 54 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.60679573 |
| 55 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.60679573 |
| 56 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.60679573 |
| 57 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.58905584 |
| 58 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.58733418 |
| 59 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53570739 |
| 60 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52372561 |
| 61 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.51872473 |
| 62 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.50833176 |
| 63 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.49429396 |
| 64 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.48951407 |
| 65 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.47289062 |
| 66 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.44102380 |
| 67 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.41617695 |
| 68 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.41559680 |
| 69 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.41448239 |
| 70 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.41055294 |
| 71 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40713059 |
| 72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.40097646 |
| 73 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.37975553 |
| 74 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.37721838 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35508988 |
| 76 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.34993150 |
| 77 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.34275622 |
| 78 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.34253525 |
| 79 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.34198624 |
| 80 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.32378804 |
| 81 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.30984792 |
| 82 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30430054 |
| 83 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29093287 |
| 84 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28409093 |
| 85 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.24141096 |
| 86 | MYB_26560356_Chip-Seq_TH2_Human | 1.23400267 |
| 87 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.23287157 |
| 88 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21964527 |
| 89 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21145110 |
| 90 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20986930 |
| 91 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.18355739 |
| 92 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.18355739 |
| 93 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.17645164 |
| 94 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16456743 |
| 95 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.14938651 |
| 96 | MYB_26560356_Chip-Seq_TH1_Human | 1.14150239 |
| 97 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13890370 |
| 98 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.13668018 |
| 99 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13232012 |
| 100 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.13129972 |
| 101 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.12769960 |
| 102 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.12743727 |
| 103 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.12390968 |
| 104 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.12210168 |
| 105 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.10974874 |
| 106 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10192696 |
| 107 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.08617360 |
| 108 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.07216297 |
| 109 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.06537874 |
| 110 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.06349069 |
| 111 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.05728004 |
| 112 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.05305847 |
| 113 | * MAF_26560356_Chip-Seq_TH2_Human | 1.04770667 |
| 114 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 1.04570381 |
| 115 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.04345712 |
| 116 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03013844 |
| 117 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03013844 |
| 118 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02150494 |
| 119 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.01587209 |
| 120 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01458656 |
| 121 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.01281867 |
| 122 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.00883198 |
| 123 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.00737578 |
| 124 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.99968656 |
| 125 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99925687 |
| 126 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.99719459 |
| 127 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99470379 |
| 128 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.99277631 |
| 129 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.99092054 |
| 130 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98558825 |
| 131 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98468157 |
| 132 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.98280650 |
| 133 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.97993706 |
| 134 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.96689925 |
| 135 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.95311072 |
| 136 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.94390627 |
| 137 | SA1_27219007_Chip-Seq_Bcells_Human | 0.94365542 |
| 138 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94158214 |
| 139 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.92244211 |
| 140 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.90799206 |
| 141 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.89771869 |
| 142 | KDM2B_26808549_Chip-Seq_K562_Human | 0.89309863 |
| 143 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.87622510 |
| 144 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.87080825 |
| 145 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.86625729 |
| 146 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.86497307 |
| 147 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.86069992 |
| 148 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.85736960 |
| 149 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.85450478 |
| 150 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.85157955 |
| 151 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.84536848 |
| 152 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.82951068 |
| 153 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 0.82731732 |
| 154 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80069208 |
| 155 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.79764728 |
| 156 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.79206529 |
| 157 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78599126 |
| 158 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.76689975 |
| 159 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75758501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005248_abnormal_Harderian_gland | 4.20682172 |
| 2 | MP0005671_abnormal_response_to | 3.70087297 |
| 3 | MP0003787_abnormal_imprinting | 3.53276210 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 3.50461845 |
| 5 | MP0010030_abnormal_orbit_morphology | 3.34376259 |
| 6 | MP0003724_increased_susceptibility_to | 3.32767017 |
| 7 | MP0002139_abnormal_hepatobiliary_system | 2.88420011 |
| 8 | MP0002132_abnormal_respiratory_system | 2.86723714 |
| 9 | MP0001835_abnormal_antigen_presentation | 2.63992404 |
| 10 | MP0001958_emphysema | 2.58226968 |
| 11 | MP0000685_abnormal_immune_system | 2.51784399 |
| 12 | MP0009840_abnormal_foam_cell | 2.26381001 |
| 13 | MP0000465_gastrointestinal_hemorrhage | 2.24327281 |
| 14 | MP0003279_aneurysm | 2.22411856 |
| 15 | MP0003656_abnormal_erythrocyte_physiolo | 2.21046107 |
| 16 | MP0005464_abnormal_platelet_physiology | 2.11908800 |
| 17 | MP0002254_reproductive_system_inflammat | 2.05937327 |
| 18 | MP0003690_abnormal_glial_cell | 2.02606426 |
| 19 | MP0004130_abnormal_muscle_cell | 2.00929191 |
| 20 | MP0009333_abnormal_splenocyte_physiolog | 1.94277442 |
| 21 | MP0005670_abnormal_white_adipose | 1.93047012 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 1.84790644 |
| 23 | MP0002909_abnormal_adrenal_gland | 1.83918255 |
| 24 | MP0001800_abnormal_humoral_immune | 1.83088522 |
| 25 | MP0005503_abnormal_tendon_morphology | 1.81933648 |
| 26 | MP0010234_abnormal_vibrissa_follicle | 1.79936532 |
| 27 | MP0001542_abnormal_bone_strength | 1.77564469 |
| 28 | MP0002876_abnormal_thyroid_physiology | 1.77125663 |
| 29 | MP0000343_altered_response_to | 1.73596249 |
| 30 | MP0003763_abnormal_thymus_physiology | 1.71180093 |
| 31 | MP0003436_decreased_susceptibility_to | 1.71078644 |
| 32 | MP0005360_urolithiasis | 1.68381154 |
| 33 | MP0004859_abnormal_synaptic_plasticity | 1.67150981 |
| 34 | MP0002398_abnormal_bone_marrow | 1.66166560 |
| 35 | MP0005000_abnormal_immune_tolerance | 1.64499947 |
| 36 | MP0005365_abnormal_bile_salt | 1.63456867 |
| 37 | MP0009278_abnormal_bone_marrow | 1.62468914 |
| 38 | MP0005275_abnormal_skin_tensile | 1.61064869 |
| 39 | MP0005387_immune_system_phenotype | 1.59748965 |
| 40 | MP0001790_abnormal_immune_system | 1.59748965 |
| 41 | MP0002420_abnormal_adaptive_immunity | 1.59364874 |
| 42 | MP0006054_spinal_hemorrhage | 1.59319297 |
| 43 | MP0002452_abnormal_antigen_presenting | 1.58997087 |
| 44 | * MP0002971_abnormal_brown_adipose | 1.57939932 |
| 45 | MP0001819_abnormal_immune_cell | 1.57805952 |
| 46 | MP0003252_abnormal_bile_duct | 1.57100530 |
| 47 | MP0006082_CNS_inflammation | 1.54902858 |
| 48 | MP0002723_abnormal_immune_serum | 1.53421980 |
| 49 | MP0010368_abnormal_lymphatic_system | 1.51554179 |
| 50 | MP0005164_abnormal_response_to | 1.50099913 |
| 51 | MP0000716_abnormal_immune_system | 1.48603488 |
| 52 | MP0003303_peritoneal_inflammation | 1.47326424 |
| 53 | MP0003075_altered_response_to | 1.46513710 |
| 54 | MP0002396_abnormal_hematopoietic_system | 1.44496012 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.41480504 |
| 56 | MP0002295_abnormal_pulmonary_circulatio | 1.40669658 |
| 57 | MP0008875_abnormal_xenobiotic_pharmacok | 1.39242117 |
| 58 | MP0005085_abnormal_gallbladder_physiolo | 1.39058860 |
| 59 | MP0000689_abnormal_spleen_morphology | 1.37825118 |
| 60 | MP0003633_abnormal_nervous_system | 1.37760808 |
| 61 | MP0002736_abnormal_nociception_after | 1.37720713 |
| 62 | MP0002722_abnormal_immune_system | 1.36987938 |
| 63 | MP0000003_abnormal_adipose_tissue | 1.36054654 |
| 64 | MP0005025_abnormal_response_to | 1.33902292 |
| 65 | MP0005058_abnormal_lysosome_morphology | 1.33004507 |
| 66 | MP0009785_altered_susceptibility_to | 1.31577406 |
| 67 | MP0004147_increased_porphyrin_level | 1.31422237 |
| 68 | MP0003705_abnormal_hypodermis_morpholog | 1.31167713 |
| 69 | MP0010329_abnormal_lipoprotein_level | 1.30917773 |
| 70 | MP0002429_abnormal_blood_cell | 1.29023727 |
| 71 | MP0002419_abnormal_innate_immunity | 1.28857178 |
| 72 | MP0003329_amyloid_beta_deposits | 1.28214342 |
| 73 | MP0000604_amyloidosis | 1.27304618 |
| 74 | MP0002998_abnormal_bone_remodeling | 1.25557940 |
| 75 | MP0003300_gastrointestinal_ulcer | 1.22376369 |
| 76 | MP0003879_abnormal_hair_cell | 1.20279070 |
| 77 | MP0005375_adipose_tissue_phenotype | 1.19174700 |
| 78 | MP0002249_abnormal_larynx_morphology | 1.18880578 |
| 79 | MP0001845_abnormal_inflammatory_respons | 1.16437028 |
| 80 | MP0005165_increased_susceptibility_to | 1.16247006 |
| 81 | MP0000681_abnormal_thyroid_gland | 1.15916874 |
| 82 | MP0003011_delayed_dark_adaptation | 1.14932079 |
| 83 | MP0000920_abnormal_myelination | 1.14315425 |
| 84 | MP0003091_abnormal_cell_migration | 1.14099599 |
| 85 | MP0005023_abnormal_wound_healing | 1.14016404 |
| 86 | MP0004019_abnormal_vitamin_homeostasis | 1.14001265 |
| 87 | MP0003183_abnormal_peptide_metabolism | 1.13611328 |
| 88 | MP0000767_abnormal_smooth_muscle | 1.12109012 |
| 89 | MP0008469_abnormal_protein_level | 1.11559346 |
| 90 | MP0001968_abnormal_touch/_nociception | 1.10393405 |
| 91 | MP0008260_abnormal_autophagy | 1.10269137 |
| 92 | MP0005595_abnormal_vascular_smooth | 1.09723112 |
| 93 | MP0004272_abnormal_basement_membrane | 1.09660450 |
| 94 | MP0000613_abnormal_salivary_gland | 1.08992585 |
| 95 | MP0002933_joint_inflammation | 1.07760803 |
| 96 | MP0002138_abnormal_hepatobiliary_system | 1.05826203 |
| 97 | MP0004808_abnormal_hematopoietic_stem | 1.04690687 |
| 98 | MP0003828_pulmonary_edema | 1.03621554 |
| 99 | MP0008877_abnormal_DNA_methylation | 1.03444971 |
| 100 | MP0005390_skeleton_phenotype | 1.01730416 |
| 101 | MP0005666_abnormal_adipose_tissue | 1.00108022 |
| 102 | MP0002148_abnormal_hypersensitivity_rea | 0.99624318 |
| 103 | MP0000703_abnormal_thymus_morphology | 0.98952895 |
| 104 | MP0002118_abnormal_lipid_homeostasis | 0.98633012 |
| 105 | MP0005646_abnormal_pituitary_gland | 0.98430674 |
| 106 | MP0003806_abnormal_nucleotide_metabolis | 0.98328348 |
| 107 | MP0000858_altered_metastatic_potential | 0.98138997 |
| 108 | MP0004510_myositis | 0.98084679 |
| 109 | MP0001501_abnormal_sleep_pattern | 0.97934626 |
| 110 | MP0002896_abnormal_bone_mineralization | 0.97313831 |
| 111 | MP0009764_decreased_sensitivity_to | 0.97127271 |
| 112 | MP0003045_fibrosis | 0.96639576 |
| 113 | MP0005075_abnormal_melanosome_morpholog | 0.95986111 |
| 114 | MP0001661_extended_life_span | 0.95946792 |
| 115 | MP0003567_abnormal_fetal_cardiomyocyte | 0.95239632 |
| 116 | MP0001756_abnormal_urination | 0.95092332 |
| 117 | MP0000249_abnormal_blood_vessel | 0.94928661 |
| 118 | MP0002405_respiratory_system_inflammati | 0.94802779 |
| 119 | MP0003566_abnormal_cell_adhesion | 0.93276945 |
| 120 | MP0009115_abnormal_fat_cell | 0.92689698 |
| 121 | MP0000609_abnormal_liver_physiology | 0.92278562 |
| 122 | MP0004883_abnormal_blood_vessel | 0.91989434 |
| 123 | * MP0005535_abnormal_body_temperature | 0.90917052 |
| 124 | MP0005332_abnormal_amino_acid | 0.90192753 |
| 125 | MP0000598_abnormal_liver_morphology | 0.89728840 |
| 126 | MP0000013_abnormal_adipose_tissue | 0.88674466 |
| 127 | MP0003635_abnormal_synaptic_transmissio | 0.88643281 |
| 128 | MP0000751_myopathy | 0.87599787 |
| 129 | MP0005167_abnormal_blood-brain_barrier | 0.87239678 |
| 130 | MP0003191_abnormal_cellular_cholesterol | 0.86380390 |
| 131 | MP0003866_abnormal_defecation | 0.86301049 |
| 132 | MP0000534_abnormal_ureter_morphology | 0.84713564 |
| 133 | MP0010155_abnormal_intestine_physiology | 0.84510590 |
| 134 | MP0002928_abnormal_bile_duct | 0.84495411 |
| 135 | MP0001533_abnormal_skeleton_physiology | 0.84304020 |
| 136 | MP0005319_abnormal_enzyme/_coenzyme | 0.83380896 |
| 137 | MP0010386_abnormal_urinary_bladder | 0.83239581 |
| 138 | MP0005645_abnormal_hypothalamus_physiol | 0.82386778 |
| 139 | MP0005257_abnormal_intraocular_pressure | 0.81586186 |
| 140 | MP0003195_calcinosis | 0.81197388 |
| 141 | MP0003795_abnormal_bone_structure | 0.81084834 |
| 142 | MP0001545_abnormal_hematopoietic_system | 0.80444160 |
| 143 | MP0005397_hematopoietic_system_phenotyp | 0.80444160 |
| 144 | MP0001944_abnormal_pancreas_morphology | 0.80311041 |
| 145 | MP0003959_abnormal_lean_body | 0.79391317 |
| 146 | MP0002133_abnormal_respiratory_system | 0.79169997 |
| 147 | MP0005388_respiratory_system_phenotype | 0.79169997 |
| 148 | MP0001853_heart_inflammation | 0.78728784 |
| 149 | MP0002078_abnormal_glucose_homeostasis | 0.77298493 |
| 150 | * MP0003631_nervous_system_phenotype | 0.77205038 |
| 151 | MP0005508_abnormal_skeleton_morphology | 0.76637308 |
| 152 | MP0008874_decreased_physiological_sensi | 0.76464081 |
| 153 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76284863 |
| 154 | MP0005334_abnormal_fat_pad | 0.76281535 |
| 155 | MP0005166_decreased_susceptibility_to | 0.74050146 |
| 156 | MP0002090_abnormal_vision | 0.73971698 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 9.21353269 |
| 2 | Annular pancreas (HP:0001734) | 6.17948423 |
| 3 | Failure to thrive in infancy (HP:0001531) | 5.23699207 |
| 4 | Hypochromic microcytic anemia (HP:0004840) | 5.15925873 |
| 5 | Abnormal pancreas size (HP:0012094) | 4.85642811 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 4.43885904 |
| 7 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.43885904 |
| 8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.43885904 |
| 9 | Weak cry (HP:0001612) | 3.92647237 |
| 10 | Protrusio acetabuli (HP:0003179) | 3.72747691 |
| 11 | Amyloidosis (HP:0011034) | 3.58490202 |
| 12 | Absent frontal sinuses (HP:0002688) | 3.55474594 |
| 13 | Stereotypic behavior (HP:0000733) | 3.51610212 |
| 14 | Aplastic anemia (HP:0001915) | 3.35861572 |
| 15 | Vascular tortuosity (HP:0004948) | 3.31132102 |
| 16 | Vertebral compression fractures (HP:0002953) | 3.22351212 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.20381793 |
| 18 | Increased cerebral lipofuscin (HP:0011813) | 3.19031135 |
| 19 | Obsessive-compulsive behavior (HP:0000722) | 3.14608166 |
| 20 | Mitral stenosis (HP:0001718) | 3.13665582 |
| 21 | Abnormal hemoglobin (HP:0011902) | 3.12843533 |
| 22 | IgM deficiency (HP:0002850) | 3.12670497 |
| 23 | Arterial tortuosity (HP:0005116) | 3.08742712 |
| 24 | Pallor (HP:0000980) | 3.06289654 |
| 25 | Small hand (HP:0200055) | 3.04884914 |
| 26 | Open mouth (HP:0000194) | 3.02046142 |
| 27 | Premature rupture of membranes (HP:0001788) | 3.00544523 |
| 28 | Febrile seizures (HP:0002373) | 2.98097586 |
| 29 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.95228618 |
| 30 | Vacuolated lymphocytes (HP:0001922) | 2.79453328 |
| 31 | Aortic aneurysm (HP:0004942) | 2.78140798 |
| 32 | Myositis (HP:0100614) | 2.77341958 |
| 33 | Neurofibrillary tangles (HP:0002185) | 2.75157595 |
| 34 | Volvulus (HP:0002580) | 2.72721603 |
| 35 | Limb hypertonia (HP:0002509) | 2.71531748 |
| 36 | Cervical subluxation (HP:0003308) | 2.69025785 |
| 37 | Hypochromic anemia (HP:0001931) | 2.65314652 |
| 38 | Joint stiffness (HP:0001387) | 2.60968598 |
| 39 | Protruding tongue (HP:0010808) | 2.60584458 |
| 40 | Multiple enchondromatosis (HP:0005701) | 2.59793570 |
| 41 | Complement deficiency (HP:0004431) | 2.59762709 |
| 42 | Abnormality of the frontal sinuses (HP:0002687) | 2.57433896 |
| 43 | Prolonged bleeding time (HP:0003010) | 2.57208935 |
| 44 | Hypercholesterolemia (HP:0003124) | 2.56239743 |
| 45 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.55704132 |
| 46 | Recurrent bronchitis (HP:0002837) | 2.55042633 |
| 47 | Tented upper lip vermilion (HP:0010804) | 2.54191296 |
| 48 | Hyperacusis (HP:0010780) | 2.52345798 |
| 49 | Inflammation of the large intestine (HP:0002037) | 2.52290863 |
| 50 | Aortic dissection (HP:0002647) | 2.51014150 |
| 51 | Glomerulonephritis (HP:0000099) | 2.49986222 |
| 52 | Cerebral aneurysm (HP:0004944) | 2.49664075 |
| 53 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.47505932 |
| 54 | Microcytic anemia (HP:0001935) | 2.44449738 |
| 55 | Increased CSF protein (HP:0002922) | 2.44099587 |
| 56 | Asymmetric septal hypertrophy (HP:0001670) | 2.43335943 |
| 57 | Deep venous thrombosis (HP:0002625) | 2.41549394 |
| 58 | Gastrointestinal inflammation (HP:0004386) | 2.40558790 |
| 59 | Bicornuate uterus (HP:0000813) | 2.38018522 |
| 60 | Nuclear cataract (HP:0100018) | 2.37779333 |
| 61 | Hypoplasia of the thymus (HP:0000778) | 2.36932015 |
| 62 | Peritonitis (HP:0002586) | 2.36453128 |
| 63 | Encephalitis (HP:0002383) | 2.34687238 |
| 64 | Chronic otitis media (HP:0000389) | 2.32958783 |
| 65 | Cellulitis (HP:0100658) | 2.29805143 |
| 66 | Myocardial infarction (HP:0001658) | 2.29366173 |
| 67 | J-shaped sella turcica (HP:0002680) | 2.28850937 |
| 68 | Colitis (HP:0002583) | 2.28535036 |
| 69 | Xanthomatosis (HP:0000991) | 2.27625852 |
| 70 | Spontaneous hematomas (HP:0007420) | 2.27543540 |
| 71 | Axonal loss (HP:0003447) | 2.27287511 |
| 72 | Increased variability in muscle fiber diameter (HP:0003557) | 2.27200763 |
| 73 | Eczematoid dermatitis (HP:0000976) | 2.26423800 |
| 74 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.23612791 |
| 75 | Loss of speech (HP:0002371) | 2.22289045 |
| 76 | Abnormality of macrophages (HP:0004311) | 2.21809640 |
| 77 | Periodontitis (HP:0000704) | 2.21553750 |
| 78 | Dilatation of the ascending aorta (HP:0005111) | 2.19621063 |
| 79 | Orchitis (HP:0100796) | 2.19497204 |
| 80 | Retrobulbar optic neuritis (HP:0100654) | 2.19489509 |
| 81 | Optic neuritis (HP:0100653) | 2.19489509 |
| 82 | Chronic diarrhea (HP:0002028) | 2.19043054 |
| 83 | Supranuclear gaze palsy (HP:0000605) | 2.17882372 |
| 84 | Epistaxis (HP:0000421) | 2.16054072 |
| 85 | Cardiovascular calcification (HP:0011915) | 2.15963226 |
| 86 | Hematochezia (HP:0002573) | 2.14137311 |
| 87 | Skin nodule (HP:0200036) | 2.09198490 |
| 88 | Recurrent fungal infections (HP:0002841) | 2.08513113 |
| 89 | Wormian bones (HP:0002645) | 2.07770398 |
| 90 | Hypertriglyceridemia (HP:0002155) | 2.06980962 |
| 91 | Systemic lupus erythematosus (HP:0002725) | 2.06468812 |
| 92 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.06387200 |
| 93 | Cerebral inclusion bodies (HP:0100314) | 2.05681235 |
| 94 | Striae distensae (HP:0001065) | 2.05065590 |
| 95 | Interstitial pulmonary disease (HP:0006530) | 2.04661075 |
| 96 | Recurrent sinusitis (HP:0011108) | 2.04555963 |
| 97 | Bone cyst (HP:0012062) | 2.02237108 |
| 98 | Ovoid vertebral bodies (HP:0003300) | 2.01539968 |
| 99 | Recurrent viral infections (HP:0004429) | 2.00540166 |
| 100 | * Progressive inability to walk (HP:0002505) | 2.00221761 |
| 101 | Aneurysm (HP:0002617) | 1.99604545 |
| 102 | Recurrent abscess formation (HP:0002722) | 1.98240999 |
| 103 | Menorrhagia (HP:0000132) | 1.96774467 |
| 104 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.96601226 |
| 105 | Mucopolysacchariduria (HP:0008155) | 1.96601226 |
| 106 | Osteomalacia (HP:0002749) | 1.94039227 |
| 107 | Progressive neurologic deterioration (HP:0002344) | 1.93968754 |
| 108 | Sensorimotor neuropathy (HP:0007141) | 1.93807021 |
| 109 | Gingival bleeding (HP:0000225) | 1.91427877 |
| 110 | Short nail (HP:0001799) | 1.91013911 |
| 111 | Joint hemorrhage (HP:0005261) | 1.90682871 |
| 112 | Nephritis (HP:0000123) | 1.90603058 |
| 113 | Dysostosis multiplex (HP:0000943) | 1.90398648 |
| 114 | Pathologic fracture (HP:0002756) | 1.88911035 |
| 115 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.88404288 |
| 116 | Episodic fever (HP:0001954) | 1.88096431 |
| 117 | Vascular calcification (HP:0004934) | 1.87721939 |
| 118 | Panhypogammaglobulinemia (HP:0003139) | 1.87579415 |
| 119 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.86858748 |
| 120 | Severe global developmental delay (HP:0011344) | 1.86559898 |
| 121 | Meningitis (HP:0001287) | 1.83727144 |
| 122 | Hyperlipoproteinemia (HP:0010980) | 1.83698680 |
| 123 | Abnormality of T cell physiology (HP:0011840) | 1.83463605 |
| 124 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.82818850 |
| 125 | Agammaglobulinemia (HP:0004432) | 1.82583900 |
| 126 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.82573269 |
| 127 | Joint swelling (HP:0001386) | 1.81250378 |
| 128 | Glucose intolerance (HP:0000833) | 1.81008917 |
| 129 | Papilledema (HP:0001085) | 1.80193687 |
| 130 | Osteolytic defects of the hand bones (HP:0009699) | 1.78664535 |
| 131 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.78664535 |
| 132 | Smooth philtrum (HP:0000319) | 1.78639692 |
| 133 | Spondylolisthesis (HP:0003302) | 1.78223599 |
| 134 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.77300269 |
| 135 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.77300269 |
| 136 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.77300269 |
| 137 | Abnormal platelet function (HP:0011869) | 1.77126537 |
| 138 | Impaired platelet aggregation (HP:0003540) | 1.77126537 |
| 139 | Broad face (HP:0000283) | 1.77086347 |
| 140 | Cheilitis (HP:0100825) | 1.76302959 |
| 141 | Chronic sinusitis (HP:0011109) | 1.76272475 |
| 142 | Abnormality of the periventricular white matter (HP:0002518) | 1.75543869 |
| 143 | Renal Fanconi syndrome (HP:0001994) | 1.75107758 |
| 144 | Gingivitis (HP:0000230) | 1.74207574 |
| 145 | Abnormality of the nasal mucosa (HP:0000433) | 1.74122502 |
| 146 | Aortic regurgitation (HP:0001659) | 1.73486430 |
| 147 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.73402587 |
| 148 | Bruising susceptibility (HP:0000978) | 1.73040968 |
| 149 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.72982377 |
| 150 | Conical tooth (HP:0000698) | 1.72912649 |
| 151 | Bradycardia (HP:0001662) | 1.72615808 |
| 152 | Polycythemia (HP:0001901) | 1.72556452 |
| 153 | Large eyes (HP:0001090) | 1.72191305 |
| 154 | Aortic valve stenosis (HP:0001650) | 1.71835953 |
| 155 | Follicular hyperkeratosis (HP:0007502) | 1.71053414 |
| 156 | Recurrent bacterial skin infections (HP:0005406) | 1.70487261 |
| 157 | Hypercortisolism (HP:0001578) | 1.70391811 |
| 158 | Hepatitis (HP:0012115) | 1.70025424 |
| 159 | Purpura (HP:0000979) | 1.68402004 |
| 160 | Abnormality of complement system (HP:0005339) | 1.68117817 |
| 161 | Abnormal eating behavior (HP:0100738) | 1.67728100 |
| 162 | Thin upper lip vermilion (HP:0000219) | 1.66221422 |
| 163 | Acanthosis nigricans (HP:0000956) | 1.65384421 |
| 164 | Hemorrhage of the eye (HP:0011885) | 1.65236404 |
| 165 | Hyperglycemia (HP:0003074) | 1.64954070 |
| 166 | Pulmonary artery stenosis (HP:0004415) | 1.64526363 |
| 167 | Abnormality of skull ossification (HP:0002703) | 1.64433990 |
| 168 | Prolonged neonatal jaundice (HP:0006579) | 1.64383868 |
| 169 | Insulin resistance (HP:0000855) | 1.62569571 |
| 170 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.59731247 |
| 171 | Scanning speech (HP:0002168) | 1.59389062 |
| 172 | Soft skin (HP:0000977) | 1.57861554 |
| 173 | Mutism (HP:0002300) | 1.56245964 |
| 174 | Action tremor (HP:0002345) | 1.55885008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR3 | 4.48098279 |
| 2 | MAP3K12 | 3.75940608 |
| 3 | SIK1 | 3.35636486 |
| 4 | MAP4K1 | 3.11215719 |
| 5 | RIPK4 | 2.63650204 |
| 6 | FGFR4 | 2.61294488 |
| 7 | CAMKK2 | 2.48811790 |
| 8 | DYRK1A | 2.40776884 |
| 9 | FES | 2.20150828 |
| 10 | ZAP70 | 2.06284604 |
| 11 | EPHB1 | 2.02554924 |
| 12 | SYK | 2.02485900 |
| 13 | DYRK1B | 2.00646220 |
| 14 | TESK1 | 1.91870916 |
| 15 | FLT3 | 1.87303372 |
| 16 | JAK3 | 1.81552760 |
| 17 | JAK1 | 1.79558075 |
| 18 | TYK2 | 1.76504168 |
| 19 | PINK1 | 1.70166250 |
| 20 | IKBKE | 1.66736178 |
| 21 | BTK | 1.56434319 |
| 22 | SIK3 | 1.55817827 |
| 23 | CSF1R | 1.51381607 |
| 24 | TGFBR2 | 1.50261986 |
| 25 | UHMK1 | 1.46175377 |
| 26 | GRK6 | 1.45951182 |
| 27 | PKN2 | 1.39934545 |
| 28 | DDR2 | 1.39409243 |
| 29 | RIPK1 | 1.38887921 |
| 30 | PTK2B | 1.35761501 |
| 31 | STK38 | 1.35423068 |
| 32 | TXK | 1.33992188 |
| 33 | ERN1 | 1.33820017 |
| 34 | MAP3K14 | 1.32205688 |
| 35 | FER | 1.31642234 |
| 36 | BLK | 1.31411882 |
| 37 | KIT | 1.27738975 |
| 38 | MOS | 1.26889858 |
| 39 | MAP3K9 | 1.26804280 |
| 40 | MAPK13 | 1.26721606 |
| 41 | BCKDK | 1.25511272 |
| 42 | FRK | 1.23741647 |
| 43 | LIMK1 | 1.22021722 |
| 44 | PRKCH | 1.21485401 |
| 45 | MAP3K6 | 1.21279936 |
| 46 | PDK1 | 1.20398451 |
| 47 | CAMKK1 | 1.19663684 |
| 48 | MAPKAPK3 | 1.18043022 |
| 49 | NEK9 | 1.17731342 |
| 50 | TAOK3 | 1.15666630 |
| 51 | EEF2K | 1.15082800 |
| 52 | MAP3K10 | 1.13230308 |
| 53 | MAP3K7 | 1.12675697 |
| 54 | MAPK12 | 1.11395916 |
| 55 | SIK2 | 1.10182290 |
| 56 | SGK3 | 1.09815050 |
| 57 | CDK6 | 1.06060498 |
| 58 | TAOK1 | 1.05120075 |
| 59 | TRPM7 | 1.04381965 |
| 60 | HCK | 1.03725556 |
| 61 | PAK6 | 1.00358630 |
| 62 | JAK2 | 1.00295624 |
| 63 | GRK5 | 0.99572210 |
| 64 | ABL2 | 0.99179851 |
| 65 | HIPK2 | 0.97883426 |
| 66 | MAP2K6 | 0.96452889 |
| 67 | EPHA3 | 0.96110662 |
| 68 | TBK1 | 0.95219944 |
| 69 | CDC42BPA | 0.92766200 |
| 70 | ARAF | 0.91924830 |
| 71 | RPS6KB2 | 0.91714630 |
| 72 | PRPF4B | 0.87393899 |
| 73 | ITK | 0.85235257 |
| 74 | KSR2 | 0.84513377 |
| 75 | MARK2 | 0.84478736 |
| 76 | PHKG1 | 0.82770305 |
| 77 | PHKG2 | 0.82770305 |
| 78 | PDPK1 | 0.81364006 |
| 79 | MAPK7 | 0.80640813 |
| 80 | NTRK2 | 0.80099665 |
| 81 | PTK2 | 0.77021202 |
| 82 | GRK7 | 0.76939772 |
| 83 | LCK | 0.76055365 |
| 84 | LYN | 0.75514257 |
| 85 | PRKG2 | 0.73225401 |
| 86 | PDGFRA | 0.73176183 |
| 87 | BMPR2 | 0.72972629 |
| 88 | LMTK2 | 0.72726969 |
| 89 | TRIB3 | 0.72203857 |
| 90 | CDK19 | 0.71733910 |
| 91 | NTRK1 | 0.71004606 |
| 92 | TNIK | 0.69535538 |
| 93 | RET | 0.69153905 |
| 94 | MARK1 | 0.69075889 |
| 95 | CSNK1G3 | 0.67553610 |
| 96 | ALK | 0.66983219 |
| 97 | PAK4 | 0.66359537 |
| 98 | PRKAA2 | 0.66081828 |
| 99 | SGK223 | 0.65618662 |
| 100 | SGK494 | 0.65618662 |
| 101 | CSNK1G1 | 0.64262489 |
| 102 | GSK3A | 0.64068144 |
| 103 | DAPK1 | 0.63064487 |
| 104 | NME2 | 0.62888176 |
| 105 | PRKD1 | 0.62627154 |
| 106 | SGK2 | 0.62314238 |
| 107 | PDGFRB | 0.60862572 |
| 108 | PTK6 | 0.60852996 |
| 109 | CDK4 | 0.59719805 |
| 110 | MAPK11 | 0.59047879 |
| 111 | ADRBK1 | 0.58496330 |
| 112 | MAP2K4 | 0.58343972 |
| 113 | PRKD2 | 0.57531617 |
| 114 | MAP3K2 | 0.57229783 |
| 115 | MAP3K3 | 0.56098198 |
| 116 | ROCK2 | 0.53737454 |
| 117 | MAP3K11 | 0.53326843 |
| 118 | PAK3 | 0.53064492 |
| 119 | MYLK | 0.52903036 |
| 120 | MAPK15 | 0.52857442 |
| 121 | TEC | 0.51236058 |
| 122 | MAP2K3 | 0.50596635 |
| 123 | CHUK | 0.50373498 |
| 124 | CDK5 | 0.49581441 |
| 125 | LRRK2 | 0.48546054 |
| 126 | TIE1 | 0.48368414 |
| 127 | FGFR2 | 0.48172733 |
| 128 | NLK | 0.48147955 |
| 129 | ABL1 | 0.47430655 |
| 130 | KDR | 0.47375163 |
| 131 | RPS6KA2 | 0.47000900 |
| 132 | MAP2K1 | 0.46562063 |
| 133 | TNK2 | 0.46416924 |
| 134 | MAP3K13 | 0.46164203 |
| 135 | MAPK4 | 0.46060072 |
| 136 | CAMK1 | 0.45746925 |
| 137 | PIK3CG | 0.45042878 |
| 138 | AKT3 | 0.45023675 |
| 139 | CSNK1G2 | 0.43862018 |
| 140 | CSNK1A1L | 0.43818395 |
| 141 | PRKCQ | 0.42807787 |
| 142 | TYRO3 | 0.41384067 |
| 143 | MAP3K1 | 0.39721264 |
| 144 | MATK | 0.39623212 |
| 145 | DAPK2 | 0.39401714 |
| 146 | CSK | 0.38061553 |
| 147 | IKBKB | 0.36360465 |
| 148 | MAPK3 | 0.35785977 |
| 149 | NTRK3 | 0.35015984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Selenocompound metabolism_Homo sapiens_hsa00450 | 5.32434833 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.49855475 |
| 3 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 2.34747754 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.24216561 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.12765739 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.09562117 |
| 7 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.87804505 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.83999541 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 1.75741102 |
| 10 | Taste transduction_Homo sapiens_hsa04742 | 1.70462305 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.63569579 |
| 12 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.59084961 |
| 13 | ABC transporters_Homo sapiens_hsa02010 | 1.58695799 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.50855816 |
| 15 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.48542451 |
| 16 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.43554612 |
| 17 | Leishmaniasis_Homo sapiens_hsa05140 | 1.36940570 |
| 18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.36250013 |
| 19 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.31738463 |
| 20 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.28793884 |
| 21 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.27469915 |
| 22 | Prion diseases_Homo sapiens_hsa05020 | 1.26178839 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.25595773 |
| 24 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.24240060 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.23994769 |
| 26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.22039037 |
| 27 | Measles_Homo sapiens_hsa05162 | 1.19961370 |
| 28 | * Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.18541176 |
| 29 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.16889331 |
| 30 | Platelet activation_Homo sapiens_hsa04611 | 1.10133258 |
| 31 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.09797439 |
| 32 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.09040080 |
| 33 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.08993030 |
| 34 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.07856126 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.07779676 |
| 36 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.06411139 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.04913773 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.01337527 |
| 39 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.00389225 |
| 40 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.98870979 |
| 41 | Lysosome_Homo sapiens_hsa04142 | 0.97053500 |
| 42 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.96502850 |
| 43 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95962332 |
| 44 | Insulin resistance_Homo sapiens_hsa04931 | 0.95700018 |
| 45 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.92516423 |
| 46 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.91571264 |
| 47 | Phagosome_Homo sapiens_hsa04145 | 0.90504913 |
| 48 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.88430445 |
| 49 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.88419506 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.88214937 |
| 51 | Olfactory transduction_Homo sapiens_hsa04740 | 0.87526484 |
| 52 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.87187095 |
| 53 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.84780265 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 0.83949472 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83782042 |
| 56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82118688 |
| 57 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.81979491 |
| 58 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.81030500 |
| 59 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.80642736 |
| 60 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.80316101 |
| 61 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.80166105 |
| 62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.79668909 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.77927753 |
| 64 | Focal adhesion_Homo sapiens_hsa04510 | 0.77532963 |
| 65 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.76085681 |
| 66 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75864206 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.75238270 |
| 68 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.74333039 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.74232247 |
| 70 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.72658510 |
| 71 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.72450991 |
| 72 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.70186925 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69867006 |
| 74 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.68378622 |
| 75 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.67807612 |
| 76 | Peroxisome_Homo sapiens_hsa04146 | 0.67547988 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.67516655 |
| 78 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.67495329 |
| 79 | Salivary secretion_Homo sapiens_hsa04970 | 0.67375541 |
| 80 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66857669 |
| 81 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.66444525 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.65770433 |
| 83 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.65449602 |
| 84 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.64882121 |
| 85 | Pertussis_Homo sapiens_hsa05133 | 0.64375399 |
| 86 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.63250461 |
| 87 | Salmonella infection_Homo sapiens_hsa05132 | 0.62011876 |
| 88 | Mineral absorption_Homo sapiens_hsa04978 | 0.61747195 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.61185466 |
| 90 | Insulin secretion_Homo sapiens_hsa04911 | 0.61033630 |
| 91 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.60737582 |
| 92 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.59751455 |
| 93 | Bile secretion_Homo sapiens_hsa04976 | 0.59702030 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59197274 |
| 95 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.58825162 |
| 96 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58630600 |
| 97 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58353547 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57825302 |
| 99 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57808993 |
| 100 | Tuberculosis_Homo sapiens_hsa05152 | 0.57791482 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57533686 |
| 102 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.57412615 |
| 103 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56218016 |
| 104 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.55753445 |
| 105 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55087872 |
| 106 | Malaria_Homo sapiens_hsa05144 | 0.54905270 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54804777 |
| 108 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54712840 |
| 109 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.54622813 |
| 110 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54481458 |
| 111 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54333705 |
| 112 | Cocaine addiction_Homo sapiens_hsa05030 | 0.54265242 |
| 113 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.53340246 |
| 114 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53094583 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52634314 |
| 116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51629973 |
| 117 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51578199 |
| 118 | Morphine addiction_Homo sapiens_hsa05032 | 0.51507705 |
| 119 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.50512175 |
| 120 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.50188987 |
| 121 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.49849553 |
| 122 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.49828284 |
| 123 | Circadian entrainment_Homo sapiens_hsa04713 | 0.49344290 |
| 124 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.49242195 |
| 125 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.49106391 |
| 126 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.48977864 |
| 127 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.48801348 |
| 128 | Long-term potentiation_Homo sapiens_hsa04720 | 0.48085669 |
| 129 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47820308 |
| 130 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.47530641 |
| 131 | Galactose metabolism_Homo sapiens_hsa00052 | 0.47033746 |
| 132 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.46673318 |
| 133 | GABAergic synapse_Homo sapiens_hsa04727 | 0.46466135 |
| 134 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46391572 |
| 135 | Amoebiasis_Homo sapiens_hsa05146 | 0.46302967 |
| 136 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.46088372 |
| 137 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.45279206 |
| 138 | Influenza A_Homo sapiens_hsa05164 | 0.45156263 |
| 139 | Legionellosis_Homo sapiens_hsa05134 | 0.45030629 |
| 140 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43486977 |
| 141 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43315386 |
| 142 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.43143586 |
| 143 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.40905979 |
| 144 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.40537598 |
| 145 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.40344250 |

